Mild Hepatic Impairment
Showing 1 - 25 of >10,000
Hepatic Impairment Trial in Hialeah (Avacopan)
Completed
- Hepatic Impairment
-
Hialeah, FloridaClinical Pharmacology of Miami, Inc.
Aug 15, 2023
Non-alcoholic Steatohepatitis, Hepatic Impairment, Cirrhosis Trial in Orlando, San Antonio, Kistarcsa (TVB-2640 - 50 mg)
Not yet recruiting
- Non-alcoholic Steatohepatitis
- +2 more
- TVB-2640 - 50 mg
-
Orlando, Florida
- +2 more
Apr 17, 2023
Patients With Mild or Moderate Hepatic Impairment Trial in Tokyo (TS-142 5 mg)
Recruiting
- Patients With Mild or Moderate Hepatic Impairment
- TS-142 5 mg
-
Tokyo, JapanTaisho Pharmaceutical Co., Ltd selected site
Dec 27, 2022
Hepatic Function Abnormal Trial (Fexinidazole (HOE239))
Not yet recruiting
- Hepatic Function Abnormal
- Fexinidazole (HOE239)
- (no location specified)
Jan 10, 2023
Hepatic Function Abnormal Trial in Germany, United States (Venglustat (GZ402671))
Recruiting
- Hepatic Function Abnormal
- Venglustat (GZ402671)
-
Miami, Florida
- +3 more
Jan 30, 2023
Diabetes Trial (Retagliptin Phosphate Tablet)
Not yet recruiting
- Diabetes
- Retagliptin Phosphate Tablet
- (no location specified)
Sep 7, 2023
Sever Aplastic Anaemia Trial in Changchun (Hetrombopag Olamine Tablet)
Completed
- Sever Aplastic Anaemia
- Hetrombopag Olamine Tablet
-
Changchun, Jilin, ChinaThe First Bethune Hospital of Jilin University
Oct 12, 2021